The Italian Registry for therapeutic apheresis. A report from the Apheresis Study Group of the Italian Society of Nephrology

Stefano Passalacqua, Emiliano Staffolani, Ghil Busnach, Dario Roccatello, Sonia Pasquali, Paolo Cappelli, Gabriele Liuzzo

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Many clinical indications and different technical issues have been reported on therapeutic apheresis: much criticism has also been recorded in several instances, mainly due to the lack of large clinical trials to validate collected data. A Registry where all the available data can be organized and analyzed therefore becomes a priority for all the professionals involved in apheresis. The purpose of this report is to describe the data submitted from 1994 to 2004 from 15,285 treatments on 1,477 patients from 44 Centers, including mainly, but not exclusively, Nephrological Units, collected by the Apheresis Study Group of the Italian Society of Nephrology in 15 Italian regions. Plasma exchange accounted for 56.2% of the procedures, and of these 50.4% were performed by filtration. Plasma treatment was used in 40.1% of procedures, namely with Protein A immunoadsorption (14.6%), LDL-Cholesterol dextran sulfate adsorption (9.7%), and semiselective cascade or double filtration (12.6%). Cell apheresis, limited to photopheresis, was used in 0.85% of cases, and whole blood treatment (direct adsorption lipoprotein, and molecular adsorption recirculating system) in 2.7%. The procedures analyzed here account for less than 20% of estimated therapeutic apheresis performed in Italy, according to the national survey of activity performed for year 2000 by the Italian Apheresis Society. Notwithstanding that the data are largely incomplete, they are sufficiently informative for a definite trend: plasma treatment with filtration on fractionation filters and adsorption must be used as often as possible, instead of plasma exchange, thus obtaining the most selective removals.

Original languageEnglish
Pages (from-to)101-106
Number of pages6
JournalJournal of Clinical Apheresis
Volume20
Issue number2
DOIs
Publication statusPublished - 2005

Fingerprint

Blood Component Removal
Nephrology
Registries
Adsorption
Plasma Exchange
Therapeutics
Photopheresis
Dextran Sulfate
Staphylococcal Protein A
LDL Cholesterol
Italy
Lipoproteins
Clinical Trials

Keywords

  • Apheresis registry
  • Italy
  • Plasma exchange
  • Plasma treatment
  • Therapeutic apheresis

ASJC Scopus subject areas

  • Hematology

Cite this

Passalacqua, S., Staffolani, E., Busnach, G., Roccatello, D., Pasquali, S., Cappelli, P., & Liuzzo, G. (2005). The Italian Registry for therapeutic apheresis. A report from the Apheresis Study Group of the Italian Society of Nephrology. Journal of Clinical Apheresis, 20(2), 101-106. https://doi.org/10.1002/jca.20037

The Italian Registry for therapeutic apheresis. A report from the Apheresis Study Group of the Italian Society of Nephrology. / Passalacqua, Stefano; Staffolani, Emiliano; Busnach, Ghil; Roccatello, Dario; Pasquali, Sonia; Cappelli, Paolo; Liuzzo, Gabriele.

In: Journal of Clinical Apheresis, Vol. 20, No. 2, 2005, p. 101-106.

Research output: Contribution to journalArticle

Passalacqua, S, Staffolani, E, Busnach, G, Roccatello, D, Pasquali, S, Cappelli, P & Liuzzo, G 2005, 'The Italian Registry for therapeutic apheresis. A report from the Apheresis Study Group of the Italian Society of Nephrology', Journal of Clinical Apheresis, vol. 20, no. 2, pp. 101-106. https://doi.org/10.1002/jca.20037
Passalacqua, Stefano ; Staffolani, Emiliano ; Busnach, Ghil ; Roccatello, Dario ; Pasquali, Sonia ; Cappelli, Paolo ; Liuzzo, Gabriele. / The Italian Registry for therapeutic apheresis. A report from the Apheresis Study Group of the Italian Society of Nephrology. In: Journal of Clinical Apheresis. 2005 ; Vol. 20, No. 2. pp. 101-106.
@article{38834df41b7e4dc88325cde971217658,
title = "The Italian Registry for therapeutic apheresis. A report from the Apheresis Study Group of the Italian Society of Nephrology",
abstract = "Many clinical indications and different technical issues have been reported on therapeutic apheresis: much criticism has also been recorded in several instances, mainly due to the lack of large clinical trials to validate collected data. A Registry where all the available data can be organized and analyzed therefore becomes a priority for all the professionals involved in apheresis. The purpose of this report is to describe the data submitted from 1994 to 2004 from 15,285 treatments on 1,477 patients from 44 Centers, including mainly, but not exclusively, Nephrological Units, collected by the Apheresis Study Group of the Italian Society of Nephrology in 15 Italian regions. Plasma exchange accounted for 56.2{\%} of the procedures, and of these 50.4{\%} were performed by filtration. Plasma treatment was used in 40.1{\%} of procedures, namely with Protein A immunoadsorption (14.6{\%}), LDL-Cholesterol dextran sulfate adsorption (9.7{\%}), and semiselective cascade or double filtration (12.6{\%}). Cell apheresis, limited to photopheresis, was used in 0.85{\%} of cases, and whole blood treatment (direct adsorption lipoprotein, and molecular adsorption recirculating system) in 2.7{\%}. The procedures analyzed here account for less than 20{\%} of estimated therapeutic apheresis performed in Italy, according to the national survey of activity performed for year 2000 by the Italian Apheresis Society. Notwithstanding that the data are largely incomplete, they are sufficiently informative for a definite trend: plasma treatment with filtration on fractionation filters and adsorption must be used as often as possible, instead of plasma exchange, thus obtaining the most selective removals.",
keywords = "Apheresis registry, Italy, Plasma exchange, Plasma treatment, Therapeutic apheresis",
author = "Stefano Passalacqua and Emiliano Staffolani and Ghil Busnach and Dario Roccatello and Sonia Pasquali and Paolo Cappelli and Gabriele Liuzzo",
year = "2005",
doi = "10.1002/jca.20037",
language = "English",
volume = "20",
pages = "101--106",
journal = "Journal of Clinical Apheresis",
issn = "0733-2459",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - The Italian Registry for therapeutic apheresis. A report from the Apheresis Study Group of the Italian Society of Nephrology

AU - Passalacqua, Stefano

AU - Staffolani, Emiliano

AU - Busnach, Ghil

AU - Roccatello, Dario

AU - Pasquali, Sonia

AU - Cappelli, Paolo

AU - Liuzzo, Gabriele

PY - 2005

Y1 - 2005

N2 - Many clinical indications and different technical issues have been reported on therapeutic apheresis: much criticism has also been recorded in several instances, mainly due to the lack of large clinical trials to validate collected data. A Registry where all the available data can be organized and analyzed therefore becomes a priority for all the professionals involved in apheresis. The purpose of this report is to describe the data submitted from 1994 to 2004 from 15,285 treatments on 1,477 patients from 44 Centers, including mainly, but not exclusively, Nephrological Units, collected by the Apheresis Study Group of the Italian Society of Nephrology in 15 Italian regions. Plasma exchange accounted for 56.2% of the procedures, and of these 50.4% were performed by filtration. Plasma treatment was used in 40.1% of procedures, namely with Protein A immunoadsorption (14.6%), LDL-Cholesterol dextran sulfate adsorption (9.7%), and semiselective cascade or double filtration (12.6%). Cell apheresis, limited to photopheresis, was used in 0.85% of cases, and whole blood treatment (direct adsorption lipoprotein, and molecular adsorption recirculating system) in 2.7%. The procedures analyzed here account for less than 20% of estimated therapeutic apheresis performed in Italy, according to the national survey of activity performed for year 2000 by the Italian Apheresis Society. Notwithstanding that the data are largely incomplete, they are sufficiently informative for a definite trend: plasma treatment with filtration on fractionation filters and adsorption must be used as often as possible, instead of plasma exchange, thus obtaining the most selective removals.

AB - Many clinical indications and different technical issues have been reported on therapeutic apheresis: much criticism has also been recorded in several instances, mainly due to the lack of large clinical trials to validate collected data. A Registry where all the available data can be organized and analyzed therefore becomes a priority for all the professionals involved in apheresis. The purpose of this report is to describe the data submitted from 1994 to 2004 from 15,285 treatments on 1,477 patients from 44 Centers, including mainly, but not exclusively, Nephrological Units, collected by the Apheresis Study Group of the Italian Society of Nephrology in 15 Italian regions. Plasma exchange accounted for 56.2% of the procedures, and of these 50.4% were performed by filtration. Plasma treatment was used in 40.1% of procedures, namely with Protein A immunoadsorption (14.6%), LDL-Cholesterol dextran sulfate adsorption (9.7%), and semiselective cascade or double filtration (12.6%). Cell apheresis, limited to photopheresis, was used in 0.85% of cases, and whole blood treatment (direct adsorption lipoprotein, and molecular adsorption recirculating system) in 2.7%. The procedures analyzed here account for less than 20% of estimated therapeutic apheresis performed in Italy, according to the national survey of activity performed for year 2000 by the Italian Apheresis Society. Notwithstanding that the data are largely incomplete, they are sufficiently informative for a definite trend: plasma treatment with filtration on fractionation filters and adsorption must be used as often as possible, instead of plasma exchange, thus obtaining the most selective removals.

KW - Apheresis registry

KW - Italy

KW - Plasma exchange

KW - Plasma treatment

KW - Therapeutic apheresis

UR - http://www.scopus.com/inward/record.url?scp=24744466513&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24744466513&partnerID=8YFLogxK

U2 - 10.1002/jca.20037

DO - 10.1002/jca.20037

M3 - Article

C2 - 15880354

AN - SCOPUS:24744466513

VL - 20

SP - 101

EP - 106

JO - Journal of Clinical Apheresis

JF - Journal of Clinical Apheresis

SN - 0733-2459

IS - 2

ER -